Multi-center MRD Registry for Inflammatory Breast Cancer
Summary
To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.
Detailed description
Primary Objectives -To determine the incidence of protocol specified pre-surgery MRD-positivity in IBC (assessment between completion of planned systemic therapy and surgery). Secondary Objectives * To establish the feasibility of multi-institutional MRD data collection using standard of care Signatera analysis in IBC participants. * To evaluate the association of pre-surgery MRD to pathologic response. * To evaluate participant reported QOL for worry about recurrence based in participants receiving MRD results * To establish protocol-optional baseline and longitudinal MRD data collection in IBC participants and report the frequency of MRD longitudinally * To determine the median lead time between the first MRD-positive result and clinical recurrence. * To determine whether adjuvant therapies decrease the amount of MRD in participants, and the association with relapse.
Arms & interventions
- BehavioralQuality-of-life Questionnaire
Participants will be asked to fill out a quality-of-life questionnaire, which will take about 10-15 minutes to complete.
Outcome measures
Primary
European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire
European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) Score scale: (1-30 questions to assess the impact of participants quality of life)
Time frame: Through study completion; an average of 1 year
Eligibility criteria
Study locations (1)
MD Anderson Cancer Center
Houston, Texas, 77030